Overview
Join us for breakfast where Dr Oliver Sartor will be joined by a panel of local experts exploring cases to highlight the key controversy areas of oligometastatic / PSMA-avid M1 / MO-CRPC and discuss how treatments might be applied in those settings.
Proudly supported by Bayer